CLINICAL_TRIALS
trial_result
· 2008-05-05
Clinical Trial Update: OculusGen-Glaucoma Historical Control Study in Taiwan [Phase 3]
Summary
Phase 3 historical control study of OculusGen for glaucoma in Taiwan has been terminated. No efficacy results are reported in this update.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pro Top & Mediking Company Limited | Conditions: Glaucoma | Phase 3 | Status: TERMINATED